Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study

Abstract Background Chronic obstructive pulmonary disease (COPD) is a progressive disease and a composite endpoint could be an indicator of treatment effect on disease worsening. This post-hoc analysis assessed whether indacaterol/glycopyrronium (IND/GLY) 110/50 μg once daily reduced the risk of cli...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Antonio R. Anzueto, Konstantinos Kostikas, Karen Mezzi, Steven Shen, Michael Larbig, Francesco Patalano, Robert Fogel, Donald Banerji, Jadwiga A. Wedzicha
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2018-06-01
coleção:	Respiratory Research
Assuntos:	Chronic obstructive pulmonary disease COPD Clinically important deterioration CID Indacaterol/glycopyrronium Salmeterol/fluticasone
Acesso em linha:	http://link.springer.com/article/10.1186/s12931-018-0830-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!